Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03639246
Title Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Aravive Biologics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Arizona Oncology Phoenix Arizona 85016 United States Details
Arizona Oncology Associates Tucson Arizona 85711 United States Details
Kaiser Permanente Oakland Oakland California 94611 United States Details
Kaiser Permanente Roseville Roseville California 95661 United States Details
Kaiser Permanente San Francisco San Francisco California 94115 United States Details
Kaiser Permanente Santa Clara Santa Clara California 95051 United States Details
Kaiser Permanente Vallejo Vallejo California 94589 United States Details
Kaiser Permanente Walnut Creek Walnut Creek California 94596 United States Details
Massachusetts General Hospital Boston Massachusetts 02214 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Washington University Saint Louis Missouri 63110 United States Details
OUHSC-Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
Willamette Valley Cancer Institute and Research Center Eugene Oregon 97401 United States Details
Texas Oncology - Austin Central Austin Texas 78731 United States Details
Texas Oncology - Fort Worth Fort Worth Texas 76104 United States Details
Texas Oncology - San Antonio Medical Center San Antonio Texas 78240 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field